IMMATICS NV- WARRANTS
IMMATICS NV- WARRANTS
Share · NL0015285958 · IMTXW (XNAS)
Overview Financial Indicators
0,02 USD
-45,26 % -0,01 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
10.06.2025 16:24

Current Prices from IMMATICS NV- WARRANTS

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
IMTXW
USD
10.06.2025 16:24
0,02 USD
0,03 USD
-45,26 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
-45,26 % -44,44 % 7,91 % -54,35 % -96,43 % -99,59 % -99,73 %

Company Profile for IMMATICS NV- WARRANTS Share

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes IMA203 that targets solid tumors, which is in Phase 1b clinical trial; IMA203CD8, a cell therapy product that is in Phase 1b clinical trial; IMA204 that targets tumor stroma, which is in preclinical stage; and IMA30x, an allogenic cellular therapy product candidate, which is in preclinical stage. The company also develops TCR Bispecifics products, including IMA401, which is in Phase 1b clinical trial; and IMA402 and IMA403, which are in preclinical stages. The company has a strategic collaboration agreement with MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies; Celgene Corporation to develop novel adoptive cell therapies targeting multiple cancers; and Genmab A/S to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics N.V. is headquartered in Tübingen, Germany.

Company Data

Name IMMATICS NV- WARRANTS
Company immatics biotechnologies GmbH
Symbol IMTXW
Website https://www.immatics.com
Primary Exchange XNAS NASDAQ
ISIN NL0015285958
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Harpreet Singh Ph.D.
Market Capitalization 387 Mio
Country United States of America
Currency USD
Employees 0,6 T
Address Paul-Ehrlich-Strasse 15, 72076 Tübingen
IPO Date 2020-07-02

Ticker Symbols

Name Symbol
NASDAQ IMTXW

More Shares

Investors who IMMATICS NV- WARRANTS hold also have the following shares in their portfolio:
APPLE 21/31
APPLE 21/31 Bond
BLUESCAPE OPPORTUNITIES ACQUISITION CORP CLASS A
BLUESCAPE OPPORTUNITIES ACQUISITION CORP CLASS A Share
E.MERGE TECHNOLOGIESLOGY ACQUISITION CORP - CLASS A
E.MERGE TECHNOLOGIESLOGY ACQUISITION CORP - CLASS A Share
INSTRUMENT KY04316G1057
INSTRUMENT KY04316G1057 Unbekannt
INSTRUMENT US3498851035
INSTRUMENT US3498851035 Unbekannt
LB.HESS.-THR.INFL.01B/14
LB.HESS.-THR.INFL.01B/14 Bond
LUMINAR TECHNOLOGIESLOGIES INC - CLASS A
LUMINAR TECHNOLOGIESLOGIES INC - CLASS A Share
MOTION ACQUISITION CORP - CLASS A
MOTION ACQUISITION CORP - CLASS A Share
NANO DIMENSION LTDICAN DEPOSITARY SHARES
NANO DIMENSION LTDICAN DEPOSITARY SHARES Depository Receipt
NEL ASA            NK-,20
NEL ASA NK-,20 Share
ORIGIN MATER. A  DL-,0001
ORIGIN MATER. A DL-,0001 Share
VECTOIQ ACQUISITION CORP II - CLASS A
VECTOIQ ACQUISITION CORP II - CLASS A Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025